HDT 211
Alternative Names: HDT-211Latest Information Update: 02 Aug 2022
Price :
$50 *
At a glance
- Originator HDT Bio
- Class Antineoplastics; Cancer vaccines; Immunotherapies; RNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Glioblastoma
Most Recent Events
- 29 Apr 2024 Early research in Glioblastoma in USA (Parenteral), prior to April 2024 (HDT Bio pipeline, April 2024)